Successful dupilumab treatment in a patient with severe dermatitis following allogenic hematopoietic stem cell transplantation
Abstract Background Allogenic hematopoietic stem cell transplantation (HSCT) is the optimal treatment of hematologic diseases and various malignancies. Development of allergic disease in a transplant patient has been reported. Case presentations A 49-year-old male with no history of atopy underwent...
Saved in:
| Main Authors: | Young-Hee Nam, Hyun Jung Jin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Allergy, Asthma & Clinical Immunology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13223-025-00966-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
by: Fabrizio Martora, et al.
Published: (2024-12-01) -
High Prevalence of Lash Collarettes in Patients with Atopic Dermatitis Treated with Dupilumab
by: Ilaria Trave, et al.
Published: (2025-08-01) -
Experience with dupilumab in patients with atopic dermatitis
by: E. A. Glukhova, et al.
Published: (2023-07-01) -
New Era in Atopic Dermatitis Treatment: Results of Long-Term Dupilumab Administration
by: Nikolay N. Murashkin, et al.
Published: (2021-11-01) -
The Effect of Dupilumab on Growth Parameters in Pediatric Atopic Dermatitis Patients
by: Vincenzo Piccolo, et al.
Published: (2025-07-01)